Sponsors (58)
The bill seeks to standardize fentanyl testing guidance and study cost-effectiveness to improve overdose diagnosis and clinical decision-making, but risks higher costs, privacy concerns, and deterring patients from seeking emergency care unless strong protections and cost mitigations are included.
Emergency department patients experiencing overdose and hospital EDs: receive clearer, evidence-based fentanyl testing policies that improve diagnosis and enable more tailored treatment.
Clinicians and hospitals: get guidance on which substances are included in routine drug tests, improving informed consent and clinical decision-making.
Hospitals and low-income patients: a required study of costs and benefits may identify cost‑effective testing practices and reduce unnecessary testing expenses.
Low-income individuals and other overdose patients: may avoid seeking emergency care if testing is recommended without clear protections, worsening health outcomes.
Patients with chronic conditions and low-income individuals: routine fentanyl testing could raise privacy and confidentiality concerns if safeguards are weak.
Hospitals and patients with chronic conditions: implementing routine fentanyl testing per guidance could create additional administrative and testing costs, potentially increasing healthcare charges.
Based on analysis of 2 sections of legislative text.
Directs HHS to study fentanyl testing in hospital EDs for overdose patients within 1 year and to issue guidance within 6 months after the study.
Requires the Department of Health and Human Services to complete a study, within one year of enactment, on hospital emergency department practices and the impacts of fentanyl testing for patients treated for overdose. Within six months after finishing the study, HHS must issue guidance—based on the study—on whether EDs should routinely perform fentanyl testing for overdose patients, how clinicians should be informed about which substances are included in routine tests, and how testing may affect future overdose risk and health outcomes.
Introduced March 10, 2025 by Ted Lieu · Last progress March 10, 2025